SEC Investigates Digital Engagement Practices in Broker Apps


Brokerage App Coercion? The SEC Wants You to Share Your Experiences

 

Stockbrokers, as part of their basic description, do not provide investment advice or portfolio management. The SEC is acting to determine whether the practices of brokerage apps such as eToro or Robinhood Cross that line. As important they are also seeking advice from professionals and retail customers to help identify where the lines should be drawn.

Background

Over 20 million new accounts have been opened at U.S. brokerages since January of last year. A substantial number of these account owners had never transacted in the securities markets before. New investors are more likely to rely on tools on the app, consult social media forums, and YouTube channels for advice – and otherwise learn through trial and error.

The Securities and Exchange Commission has as its top two priorities to protect investors and maintain fair, orderly, and efficient markets. The rapid pace of technological change, coupled with an industry that flourished as people stayed home from work while receiving stimulus checks, has the SEC playing catch-up on designing rules and standards to protect investors and to ensure fairness.

Keeping in mind that brokers are not advisors; that is, they are there to execute with your best interest in mind, but not to give advice, the SEC opened a comment period on the bells, whistles, pop-ups, and other rewards and inducements on these brokerage sites. For example, eToro allows the ability to copy portfolios of other traders. Does this cross the line into giving investment advice? Robinhood had a digital “scratch-off” where account owners could get a free stock share. The SEC is moving to determine if some digital engagement practices (DEP) are actually investment advice.

 

Source:  SEC Press release dated 8/27/21

 

SEC Policing Digital Cues

An SEC panel met Thursday (September 9) to discuss digital cues from online brokers to determine if they may potentially harm investors by coaxing them to make decisions that end up costing money. Also, to address the rise of new ways to buy stocks, options, and other public market securities.

There were two major conclusions from the panel meeting. First is that an in-depth analysis could put the SEC in a unique position to review the technology used by brokerage firms and investment advisors to reach customers and track their actions. The other conclusion was that policing digital cues is complicated, and perhaps impossible.

Before New Rules are Set

The SEC is entering into a public comment period to hear the broader open discussion before proposing any new regulatory guardrails for online trading and advisory apps. The reach of any new rules could also impact the so-called robo-advisors like Wealthfront and Betterment and more traditional online brokers that have adopted some of the newer business practices.

 

Take-Away

The impact of digital engagement such as alerts, prompts and prizes that many new stock traders encounter online is not easy to determine. If clearer guidelines are not set, we may see legal cases deciding this using Regulation Best Interest which says that brokers and advisors have to do what is in their client’s best interest.

Some prompts on platforms are there to help increase transactions; does that make it a recommendation? Can these be considered manipulative? The comment period to the SEC ends October 1st, 2021. They have asked retail investors with experience with online investment platforms to share those experiences using
this questionnaire.

 

Suggested Reading:



Will Robinhood Be Fined on Charges of Gamification?



Coinbase Receives an Enforcement Letter from the SEC





New Jersey Issues Cease and Desist Order on Crypto Payments



Can You Invest in Uranium Directly?

 

Sources:

https://www.sec.gov/news/press-release/2021-167

https://www.sec.gov/rules/other/2021/34-92766.pdf


https://www.barrons.com/articles/brokers-bells-and-whistles-can-harm-investors-sec-panel-finds-51631222273?mod=hp_LEAD_2_B_2

https://www.barrons.com/articles/secs-gamification-review-will-examine-stock-app-designs-51630101406?mod=article_inline

 

Stay up to date. Follow us:

 

QuickChek – September 10, 2021



Capstone Green Energy To Provide Ontario Greenhouse with Clean Combined Heat and Power Microgrid Solution

Capstone Green Energy announced its North American distributor, Vergent Power Solutions, has signed an agreement to provide an energy efficient, low emission, one-megawatt Combined Heat and Power (CHP) microturbine for a large greenhouse expansion in Ontario, Canada

Research, News & Market Data on Capstone Green Energy

Watch recent presentation from Capstone Green Energy



Kratos Awarded $2.8 Million to Prototype Infrastructure Hardware and Software for Unified Data Library (UDL) to Support U.S. DoD

Kratos Defense & Security Solutions announced that the Space Systems Command (SSC) awarded the company $2.8 million in funding to develop a prototype that automatically delivers space-related Situational Awareness data to the Unified Data Library

Research, News & Market Data on Kratos



Namaste Technologies Continues Evolution to Wellness and Confirms Corporate Name Change to Lifeist Wellness Inc.

Namaste Technologies announced a corporate update including a board-approved name change to Lifeist Wellness Inc. under its updated ticker symbol (LFST) on or about September 15, 2021

News & Market Data on Namaste

 

Stay up to date. Follow us:

 

Ayala Pharmaceuticals (AYLA) – Looking Forward To AL101 Data Presentation

Friday, September 10, 2021

Ayala Pharmaceuticals (AYLA)
Looking Forward To AL101 Data Presentation

Ayala Pharmaceuticals Inc clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers, primarily in genetically defined patient populations. The company’s current portfolio of product candidates, AL101 and AL102, targets the aberrant activation of the Notch pathway with gamma secretase inhibitors. Its product candidate, AL101, is being developed as a potent, selective, injectable small molecule gamma secretase inhibitor, or GSI. It is also developing AL101 for the treatment of T-ALL, an aggressive, rare form of T-cell specific leukemia.

Robert LeBoyer, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    AL101 Data Expected Shortly.  Ayala plans to present data from AL101 at the European Society for Medical Oncology (ESMO) Virtual Congress 2021, to be held September 16-September 21, 2021. The first presentation is from the Phase 2 ACCURACY clinical trial testing AL101 in recurrent/metastatic (R/M) adenoid cystic carcinoma (ACC) with Notch-activating mutations. A second preclinical study testing AL101 as combination therapy for dual targeting of Notch dysregulated tumors will also be presented.

    Data Presentation Is From The Second Dose Level.  The data will be from the second cohort in the ACCURACY trial that received the 6 mg dose. This cohort enrolled 42 patients with recurrent or metastatic adenoid cystic carcinoma (R/M ACC) and Notch-activating mutations. In September 2020, data from the first cohort of 45 patients receiving a 4mg dose of AL101 showed a disease control rate of 68% …



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

FenixOro Gold Corp. (FDVXF) – A Gold Discovery in One of Colombias Richest Mineral Belts

Friday, September 10, 2021

FenixOro Gold Corp. (FDVXF)
A Gold Discovery in One of Colombia’s Richest Mineral Belts

FenixOro Gold Corp is a Toronto based company acquiring and exploring high grade gold projects in Colombia. The company’s flagship Abriaqui Project is the nearest exploration project to Continental Gold’s Buritica Mine.

Mark Reichman, Senior Research Analyst of Natural Resources, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    Initiating coverage. We are initiating coverage of FenixOro Gold Corp. FenixOro is advancing the Abriaqui gold project in Colombia. Currently, there are two concession areas, a northern group of three contiguous concessions, and a non-contiguous concession in the southern portion of the project area comprising 547 hectares of land. The company is in the process of acquiring the mineral rights for an adjacent property encompassing 848 hectares from Polo Resources.

    Colombia compares favorably to mining jurisdictions in Latin America.  Abriaqui is in Colombia, which ranked 28th among 77 mining jurisdictions for investment attractiveness in the 2020 Fraser Institute Annual Survey of Mining Companies. Colombia ranked first among countries in Latin America and the Caribbean Basin, including Brazil (38th), Chile (30th), Ecuador (58th), Mexico (42nd), and Peru …



This research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

Gevo Inc. (GEVO) – LOI to Partner with Chevron is a Major Validation for GEVO

Friday, September 10, 2021

Gevo, Inc. (GEVO)
LOI to Partner with Chevron is a Major Validation for GEVO

Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. Its operating segments are the Gevo segment and the Gevo Development/Agri-Energy segment. By its segments, it is involved in research and development activities related to the future production of isobutanol, including the development of its biocatalysts, the production and sale of biojet fuel, its Retrofit process and the next generation of chemicals and biofuels that will be based on its isobutanol technology. Gevo Development/Agri-Energy is the key revenue generating segment which involves the operation of the Luverne Facility and production of ethanol, isobutanol and related products.

Poe Fratt, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    Letter of intent (LOI) with Chevron (CVX) is a game changer. Not only does the addition of a major integrated oil company as a partner and investor validate the renewable fuels concept, visibility improves on the funding and off take fronts. LOI is subject to finalizing terms of the co-investment agreement and the fuel supply agreement by May 31, 2022. CVX also receives 15 million warrants with a minimum strike price of $8.50/share.

    Co-investment agreement improves funding.  CVX expects to co-invest in renewable fuel plants with total capacity of up to 150 MGPY. With current project cost estimates of $980 million for a 46 MPGY plant and a debt/equity mix of 65/35, the co-investment could approach $1.0 billion, or 49% interest in three plants at $345 million/plant. In addition, the warrants could generate an additional $127.5 …



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

Release – Kratos Awarded $2.8 Million to Prototype Infrastructure Hardware and Software for Unified Data Library (UDL) to Support U.S. DoD


Kratos Awarded $2.8 Million to Prototype Infrastructure Hardware and Software for Unified Data Library (UDL) to Support U.S. DoD

 

Solution would allow space-related situational awareness data to be quickly accessible to commanders

SAN DIEGO
Sept. 10, 2021 (GLOBE NEWSWIRE) — 
Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a leading National Security Solutions provider, announced today that the Space Systems Command (SSC) awarded the company 
$2.8 million in funding to develop a prototype that automatically delivers space-related Situational Awareness (SA) data to the 
Unified Data Library (UDL). The UDL is a joint initiative of the 
Air Force Research Laboratory and the Space Force’s Space Systems Command. The cloud-based platform hosts space situational awareness data from dozens of commercial, academic and government organizations and provides a digital “storefront” for users of the data.

Today, 
DoD satellite operators utilize disparate tools, networks and data sources at varying classification levels to attempt to build a picture of the Radio Frequency (RF) environment. Kratos’ award includes developing hardware and software infrastructure that can deliver SA data to the UDL for display and analysis. This virtualized infrastructure would be a unifying tool across entities, providing the Government’s Common Operating Environment (COE) access to near-real time SATCOM spectral data, including RF signal environment factors such as Electro Magnetic Interference (EMI) alerts, and signal geolocation data at appropriate security levels.

“An infrastructure that gives immediate access to the space-related SA data the UDL provides will be critical,” commented  Frank Backes, Senior Vice President, Kratos Space Federal. “Future adversaries may interfere with large numbers of commercial SATCOM links. The UDL and RF sensor networks will help identify and address those interferers with data coming from a variety of sources including Kratos’ own global sensor network.”

One of the sources of data to the UDL, Kratos operates a global sensor network that supplies to UDL, composed of worldwide RF monitoring sites with steerable sensors and antennas covering L, S, C, X, and Ku bands. Kratos’ state-of-the-art technology for high-speed, accurate signal measurement enables advanced analytics for Space Domain Awareness (SDA). Kratos’ 24/7/365 
Network Operations Center (NOC) is the central hub for monitoring and integrating raw RF data from its global sensor network. Advanced capabilities developed by Kratos have been integrated into all levels of the infrastructure, from custom algorithms employed in the sensor network, to industry-leading commercial applications used in the NOC for data monitoring, correlation and geolocation, as well as specially developed analytics that provide real meaning behind the raw data. A portfolio of services offered to government and commercial customers include satellite position and maneuver detection, signal characterization, interference detection, attribution, and mitigation and signal geolocation.

About Kratos Defense & Security Solutions

Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS) develops and fields transformative, affordable technology, platforms and systems for United States National Security related customers, allies and commercial enterprises. Kratos is changing the way breakthrough technology for these industries are rapidly brought to market through proven commercial and venture capital backed approaches, including proactive research and streamlined development processes. At Kratos, affordability is a technology and we specialize in unmanned systems, satellite communications, cyber security/warfare, microwave electronics, missile defense, hypersonic systems, training, combat systems and next generation turbo jet and turbo fan engine development. For more information go to www.KratosDefense.com.

Notice Regarding Forward-Looking Statements
Certain statements in this press release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are made on the basis of the current beliefs, expectations and assumptions of the management of Kratos and are subject to significant risks and uncertainty. Investors are cautioned not to place undue reliance on any such forward-looking statements. All such forward-looking statements speak only as of the date they are made, and Kratos undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise. Although Kratos believes that the expectations reflected in these forward-looking statements are reasonable, these statements involve many risks and uncertainties that may cause actual results to differ materially from what may be expressed or implied in these forward-looking statements. For a further discussion of risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Kratos in general, see the risk disclosures in the Annual Report on Form 10-K of Kratos for the year ended 
December 27, 2020, and in subsequent reports on Forms 10-Q and 8-K and other filings made with the 
SEC by Kratos.

Press Contact:
Yolanda White
858-812-7302 Direct

Investor Information:
877-934-4687
investor@kratosdefense.com 

Source: Kratos Defense & Security Solutions, Inc.

Release – Capstone Green Energy To Provide Ontario Greenhouse with Clean Combined Heat and Power Microgrid Solution

 


Capstone Green Energy To Provide Ontario Greenhouse with Clean Combined Heat and Power Microgrid Solution

 

Microgrid To Be Built Around Capstone’s Low Emission C1000S Microturbine System

VAN NUYS, CA / ACCESSWIRE / September 10, 2021 / Capstone Green Energy Corporation (www.CapstoneGreenEnergy.com) (NASDAQ:CGRN), a global leader in carbon reduction and on-site resilient green energy solutions, announced that its North American distributor, Vergent Power Solutions, has signed an agreement to provide an energy efficient, low emission, one-megawatt Combined Heat and Power (CHP) microturbine for a large greenhouse expansion in Ontario, Canada.

Fueled by high pressure clean burning natural gas, the new off-grid system featuring Capstone’s C1000S will provide 24/7/365 power to the farm’s 100-acre indoor greenhouse expansion, an operation that requires a high degree of uptime and low maintenance. The design will feature inverter-based electronics to synchronize with a solar photovoltaic (PV) array in a standalone microgrid. Capstone microturbines should allow the site to have virtually 100% availability, resulting in seamless greenhouse operations. Further, the system will be designed to use the microturbines’ waste heat to both produce hot water and to provide clean carbon dioxide to the greenhouse. The systems is planned for commissioning in spring 2022, and is expected to achieve a total system energy efficiency of close to 90%.

“As Ontario’s greenhouse industry has continued to expand, its power requirements have outpaced the capabilities of the local electric utilities. This has resulted in many greenhouses going off-grid and using CHP as the primary source of energy for their operations,” said Justin Rathke, President of Vergent Power Solutions. “The customer chose Capstone due to the technology’s high uptime, low maintenance requirements, redundant bay design and clean emissions,” added Mr. Rathke.

“Modern farming practices are evolving in exciting new ways, and their energy strategies need to evolve with them,” said Darren Jamison, President and Chief Executive Officer of Capstone Green Energy. “Capstone solutions deliver essential power reliability and energy efficiency that indoor farming operations require, which, in turn, improves their return on investment. At the same time, our systems lower their carbon footprint, which critically important for an industry dependent on a healthy environment,” concluded Mr. Jamison.

About Capstone Green Energy

Capstone Green Energy (www.CapstoneGreenEnergy.com) (NASDAQ:CGRN) is a leading provider of customized microgrid solutions and on-site energy technology systems focused on helping customers around the globe meet their environmental, energy savings, and resiliency goals. Capstone Green Energy focuses on four key business lines. Through its Energy as a Service (EaaS) business, it offers rental solutions utilizing its microturbine energy systems and battery storage systems, comprehensive Factory Protection Plan (FPP) service contracts that guarantee life-cycle costs, as well as aftermarket parts. Energy Conversion Products are driven by the Company’s industry-leading, highly efficient, low-emission, resilient microturbine energy systems offering scalable solutions in addition to a broad range of customer-tailored solutions, including hybrid energy systems and larger frame industrial turbines. The Energy Storage Products business line designs and installs microgrid storage systems creating customized solutions using a combination of battery technologies and monitoring software. Through Hydrogen Energy Solutions, Capstone Green Energy offers customers a variety of hydrogen products, including the Company’s microturbine energy systems.

For customers with limited capital or short-term needs, Capstone offers rental systems; for more information, contact: rentals@CGRNenergy.com. To date, Capstone has shipped over 10,000 units to 83 countries and estimates that, in FY21, it saved customers over $217 million in annual energy costs and approximately 397,000 tons of carbon. Total savings over the last three years are estimated at 1,115,100 tons of carbon and $698 million in annual energy savings.

For more information about the Company, please visit: www.CapstoneGreenEnergy.com. Follow Capstone Green Energy on TwitterLinkedInInstagramFacebook, and YouTube.

Cautionary Note Regarding Forward-Looking Statements

This release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, including statements regarding expectations for green initiatives and execution on the Company’s growth strategy and other statements regarding the Company’s expectations, beliefs, plans, intentions, and strategies. The Company has tried to identify these forward-looking statements by using words such as “expect,” “anticipate,” “believe,” “could,” “should,” “estimate,” “intend,” “may,” “will,” “plan,” “goal” and similar terms and phrases, but such words, terms and phrases are not the exclusive means of identifying such statements. Actual results, performance and achievements could differ materially from those expressed in, or implied by, these forward-looking statements due to a variety of risks, uncertainties and other factors, including, but not limited to, the following: the ongoing effects of the COVID-19 pandemic; the availability of credit and compliance with the agreements governing the Company’s indebtedness; the Company’s ability to develop new products and enhance existing products; product quality issues, including the adequacy of reserves therefor and warranty cost exposure; intense competition; financial performance of the oil and natural gas industry and other general business, industry and economic conditions; the Company’s ability to adequately protect its intellectual property rights; and the impact of pending or threatened litigation. For a detailed discussion of factors that could affect the Company’s future operating results, please see the Company’s filings with the Securities and Exchange Commission, including the disclosures under “Risk Factors” in those filings. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, changed circumstances or future events or for any other reason.

CONTACT:
Capstone Green Energy
Investor and investment media inquiries:
818-407-3628
ir@CGRNenergy.com

SOURCE: Capstone Green Energy Corporation

Release – Namaste Technologies Continues Evolution to Wellness and Confirms Corporate Name Change to Lifeist Wellness Inc.

 

 

 


Namaste Technologies Continues Evolution to Wellness and Confirms Corporate Name Change to Lifeist Wellness Inc.

 

  • Lifeist Wellness Inc. Expected to Commence Trading on the TSX Venture Exchange Under the Ticker Symbol “LFST” on or About September 15, 2021
  • UK Product Offering Expands to include Hemp Derived CBD Products

TORONTO, September 9, 2021 — Namaste Technologies Inc. (““Lifeist”” or the “Company”) (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) leverages advancements in science and technology to enable you to find your path to wellness, is pleased to announce a corporate update including that the board has approved a name change from Namaste Technologies Inc. Trading of the Company’s common shares under its updated ticker symbol (“LFST”) is expected to commence on the TSX Venture Exchange (the “TSXV”), at market opening on or about September 15, 2021.

“Lifeist seeks to be a bold and disruptive wellness company, striving to connect humanity with safe, innovative and often daring pathways to individual definitions of wellness,” said Meni Morim, CEO of Lifeist. “The Lifeist rebrand speaks to ‘Higher Living’, resonating with a multi-billion dollar global market of consumers seeking to unlock their extraordinary. It’s an exciting time for the Company and its continued evolution to wellness as we look forward to complimenting the Company’s current portfolio of wellness of cannabis, hemp derived CBD and accessories, by delivering on our promise to establish a nutraceuticals division by the end of Q4, 2021.”

Visit the Company’s new website to learn more about Lifeist: https://lifeist.com.

Hemp derived CBD in the UK at Everyonedoes.co.uk

Within the Lifeist portfolio of wellness interests lies the UK wellness website everyonedoesit.co.uk. Lifeist is pleased to announce expansion of its product offering to include hemp derived CBD products. Lifeist seeks to tap into the second largest global market for hemp-derived CBD estimated to generate £700 million in annual sales for 2021 according to the Association for the Cannabinoid Industry and Centre for Medicinal Cannabis.

About Lifeist Wellness Inc.

Lifeist (previously Namaste Technologies Inc.) is at the forefront of the post-pandemic wellness revolution, a portfolio wellness company leveraging advancements in science and technology to enable you to find your path to wellness. Portfolio business interests include: CannMart.com that provides Canadian customers with a diverse selection of cannabis products and accessories, and its U.S. customers with hemp-derived CBD and smoking accessories; CannMart’s Canadian recreational cannabis distribution business facilitating sales to a number of provincial government control boards; and CannMart Labs Inc., a state-of-the-art BHO extraction facility set to produce higher margin cannabis concentrate products. The Company is also set to launch a new nutraceuticals division in Q4 2021 with disruptive products in wellness.

Find us at:

www.lifeist.com

Cannmart.com

everyonedoesit.co.uk

For more information please contact:
Lifeist Wellness Inc.
Meni Morim, CEO
Edward Miller, VP Investor Relations
Ph: 647-362-0390
Email: ir@lifeist.com

Source: Lifeist Wellness Inc.

FORWARD-LOOKING INFORMATION – This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not historical in nature contain forward-looking information. Forward-looking information can be identified by words or phrases such as “may”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen.

The forward-looking information contained herein, including the Company’s continued evolution into a wellness company, the anticipated launch of a nutraceutical division in the fourth quarter of 2021 and the expected date by which the company’s common shares will trade under the Company’s new symbol on the TSXV are only predictions and are made as of the date of this news release. Various assumptions were used in developing the forward-looking information throughout this news release which management believed to be reasonable at the time such statements were made, including expectations that the introduction of new divisions, products and brands will generate additional revenue, management’s perceptions of Lifeist’s standing in the online marketplace for wellness, cannabis and related products and accessories, Lifeist’s beliefs regarding the expected demand for wellness, cannabis and related products and accessories and the expected growth of that market, the Company’s ability to comply with TSXV requirements for its shares to begin trading under the new ticker symbol on the TSXV as anticipated, results of operations, operational matters, historical trends, current conditions and expected future developments, as well as other considerations that are believed to be appropriate in the circumstances. While we consider these assumptions to be reasonable based on information currently available to management, there is no assurance that such expectations will prove to be correct. By its nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this press release. Such factors include, without limitation: risks relating to the Company’s ability to develop and execute its business strategy as anticipated and in a timely manner and the benefits realizable therefrom, risks specifically related to the Company’s operations, and risks relating to the Company’s ability to successfully operate everywhere in a virtual environment and its ability to meet all applicable requirements for its shares to begin trading under its new symbol on or about September 15, 2021. Additional risk factors can also be found in the Company’s current MD&A and annual information form, both of which have been filed under the Company’s SEDAR profile at www.sedar.com. Readers are cautioned not to put undue reliance on forward-looking information. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable law. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.

Euroseas Ltd. (ESEA) – An Extraordinary Data Point Boosts EBITDA Estimates

Thursday, September 09, 2021

Euroseas Ltd. (ESEA)
An Extraordinary Data Point Boosts EBITDA Estimates

Euroseas Ltd. provides ocean-going transportation services worldwide. The company owns and operates containerships that transport dry and refrigerated containerized cargoes, including manufactured products and perishables; and drybulk carriers that transport iron ore, coal, grains, bauxite, phosphate, and fertilizers. As of March 31, 2017, it had a fleet of seven containerships; and six drybulk carriers, including three Panamax drybulk carriers, one Handymax drybulk carrier, one Kamsarmax drybulk carrier, and one Ultramax drybulk carrier. The company was founded in 2005 and is based in Maroussi, Greece.

Poe Fratt, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    Short charter on the Oakland intermediate secured at an extraordinary rate of at least $195k/day. Yesterday morning, news hit that the 2009-built Oakland intermediate secured a short charter of 60—85 days at a TCE rate of at least $195.0k/day. The charter, which should start by the end of October, could generate gross TCE revenue of at least $11.7 million.

    Container market remains firm and upcoming fixtures should be favorable.  Charters on the Oakland, Jonathan P and Diamantis P are good examples of a strong container market. Four feeders (Corfu/Evridiki G/Astoria/Aegean Express) and one intermediate (Oakland) are available for charter over the next six months …



This research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

InPlay Oil (IPOOF)(IPO:CA) – New 2022 Guidance Highlights Value of Stock Price Target Raised

Thursday, September 09, 2021

InPlay Oil (IPOOF)(IPO:CA)
New 2022 Guidance Highlights Value of Stock, Price Target Raised

As of April 24, 2020, Noble Capital Markets research on InPlay Oil is published under ticker symbols (IPOOF and IPO:CA). The price target is in USD and based on ticker symbol IPOOF. Research reports dated prior to April 24, 2020 may not follow these guidelines and could account for a variance in the price target. InPlay Oil is a junior oil and gas exploration and production company with operations in Alberta focused on light oil production. The company operates long-lived, low-decline properties with drilling development and enhanced oil recovery potential as well as undeveloped lands with exploration possibilities. The common shares of InPlay trade on the Toronto Stock Exchange under the symbol IPO and the OTCQZ Exchange under the symbol IPOOF.

Michael Heim, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    InPlay management gave updated end-of-the-year and initial 2022 production and cash flow guidance. Guidance was above our expectations, reflecting the strong performance of recent wells drilled in the Pembina Cardium. Production guidance for 2021 at the high end of the previous range of 5,500-5,750 boe/d is above our model assumptions of 5,613 boe/d. Initial guidance for 2022 is even more impressive at 6,300-6,550 boe/d versus our assumptions of 5,894 boe/d. The company has increased its capital budget and clearly expects favorable drilling results at Pembina to continue.

    Favorable production means higher cash flow.  Management estimates that based on current energy prices, it will generate Adjusted Funds Flow of C$71.5-$74.5 million in 2022. This is significantly above our estimate of C$47.3 million and is roughly equal to the current market capitalization of the company on the Canadian exchange. Estimated free cash flow of C$38-$40 million will allow the company to …



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

Release – Kratos Provides Multiple Advanced Missile Targets For Flight Test Aegis Weapon System 33


Kratos Provides Multiple Advanced Missile Targets For Flight Test Aegis Weapon System 33 (FTM-33)

 

SAN DIEGO
Sept. 09, 2021 (GLOBE NEWSWIRE) — 
Kratos Defense & Security Solutions, Inc. (Nasdaq:KTOS), a leading National Security Solutions provider, announced today that its Space & Missile Defense Systems Business Unit, a part of Kratos’ 
Defense & Rocket Support Services Division, supported the 
Missile Defense Agency (MDA) and the 
United States Navy in the successful launch of two SRBM targets during the execution of Flight Test Aegis Weapon System 33 (FTM-33). The flight test mission was the most complex mission executed by MDA and the third flight test of an Aegis Ballistic Missile Defense-equipped vessel using the SM-6 Dual II missile. A total of four SM-6 Dual II missiles were launched on 
July 24 against a raid of two advanced guided ballistic missile targets in broad ocean area northwest of 
Hawaii.

Kratos, along with the 
Naval Surface Warfare Center, Port Hueneme Division’s White Sands Detachment (NSWC PHD WSD), provided the guided missile targets for the exercise which featured Kratos’ Oriole Rocket System with Thrust Vector Control. The Kratos guided targets met all test objectives for the mission after being launched successfully from the Pacific Missile Range Facility (PMRF) on 
Kauai. The Arleigh Burke class destroyer, USS Ralph Johnson (DDG 114) was the firing ship for the test, employing four SM-6 Dual II interceptors. The SM-6 Dual II missile is designed for use in terminal phase engagements of short-to-medium range ballistic missiles.  

Dave Carter, President of the 
Kratos Defense & Rocket Support Services (KDRSS) Division, said, “The Kratos team derives a great deal of satisfaction from consistently providing all manner of successful targets in support of advancing the US Military’s warfighting capabilities and objectives. This is just another example of the exceptional work that the talented team of professionals at NSWC and 
Kratos Space & Missile Defense Systems is capable of. I am very proud of all that our team accomplished in supporting the MDA’s most complex mission to date.”

About Kratos Defense & Security Solutions

Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS) develops and fields transformative, affordable technology, platforms and systems for United States National Security related customers, allies and commercial enterprises. Kratos is changing the way breakthrough technology for these industries are rapidly brought to market through proven commercial and venture capital backed approaches, including proactive research and streamlined development processes. At Kratos, affordability is a technology, and we specialize in unmanned systems, satellite communications, cyber security/warfare, microwave electronics, missile defense, hypersonic systems, training, combat systems and next generation turbo jet and turbo fan engine development. For more information go to www.KratosDefense.com.

Notice Regarding Forward-Looking Statements
Certain statements in this press release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are made on the basis of the current beliefs, expectations and assumptions of the management of Kratos and are subject to significant risks and uncertainty. Investors are cautioned not to place undue reliance on any such forward-looking statements. All such forward-looking statements speak only as of the date they are made, and Kratos undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise. Although Kratos believes that the expectations reflected in these forward-looking statements are reasonable, these statements involve many risks and uncertainties that may cause actual results to differ materially from what may be expressed or implied in these forward-looking statements. For a further discussion of risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Kratos in general, see the risk disclosures in the Annual Report on Form 10-K of Kratos for the year ended 
December 27, 2020, and in subsequent reports on Forms 10-Q and 8-K and other filings made with the 
SEC by Kratos.

Press Contact:
Yolanda White
858-812-7302 Direct

Investor Information:
877-934-4687
investor@kratosdefense.com

Source: Kratos Defense & Security Solutions, Inc.

Release – PDS Biotech Completes Enrollment of Lead-In Safety Cohort in VERSATILE-002 Phase 2 Combination Trial of PDS0101-KEYTRUDA in Recurrent or Metastatic Head and Neck Cancer


PDS Biotech Completes Enrollment of Lead-In Safety Cohort in VERSATILE-002 Phase 2 Combination Trial of PDS0101-KEYTRUDA® in Recurrent or Metastatic Head and Neck Cancer

 

FLORHAM PARK, N.J., Sept. 09, 2021 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies based on the Company’s proprietary Versamune® T-cell activating technology, today announced that it has completed the enrollment of the lead-in safety cohort of its VERSATILE-002 Phase 2 study evaluating the efficacy and safety of the combination of PDS0101, a clinical stage immunotherapy to treat cancers caused by infection with the human papillomavirus (HPV), and KEYTRUDA® (pembrolizumab), a checkpoint inhibitor (CPI). The combination is being studied for the treatment of advanced human papillomavirus (HPV16)-associated head and neck cancer that has returned or spread. The trial is being conducted in collaboration with Merck & Co.

The VERSATILE-002 Phase 2 trial is a multi-center, open label, single arm, non-randomized trial that will enroll approximately 100 patients across approximately 25 sites in the U.S. Today the study achieved an important milestone by completing the enrollment of the lead-in safety cohort. Consistent with the study design, further recruitment for the study will commence after a formal analysis by the drug monitoring committee.

VERSATILE-002 is being studied in two groups of HPV16-positive head and neck cancer patients whose cancer has returned or spread. The first group have not been previously treated with a checkpoint inhibitor (CPI naïve). The second group of patients have failed multiple treatments including CPI therapy (CPI refractory).

The advancement of the VERSATILE-002 trial follows the previously disclosed presentation at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting of interim data in a separate Phase 2 trial (NCT04287868) being led by the National Cancer Institute (NCI). That trial is evaluating the combination of PDS0101 with two investigational immunotherapies in patients with advanced HPV-related cancers who have failed prior treatment. Objective responses measured according to RECIST 1.1 (tumor reduction of 30% or more) were reported in 83% (5/6) of HPV16-positive patients who had failed chemotherapy and radiation but were CPI naive. In CPI refractory patients, tumor reduction was reported in 58% (7/12) and objective responses in 42%. Two patients, one in each group were reported to have a complete response (no evidence of disease) at the time of reporting. Current standard of care is reported to result in objective responses of approximately 20% and 10% in CPI naïve and refractory patients respectively. More information on this study can be found on PDS Biotech’s website.

“The early data from these initial studies suggest that Versamune®-based immunotherapies administered in combinations that include a checkpoint inhibitor, may have the potential to enhance the immune system’s ability to induce a more powerful and targeted anti-tumor response,” commented Dr. Lauren V. Wood, Chief Medical Officer of PDS Biotech. “There is an enormous unmet medical need for more effective treatment of advanced HPV-related cancers and specifically, head and neck cancer. We believe the combination of PDS0101 and KEYTRUDA® has the potential to significantly improve clinical outcomes for these patients who have limited treatment options. We look forward to sharing data from this trial as they become available.”

Dr. Jared Weiss, Section Chief of Thoracic and Head and Neck Oncology at the University of Carolina at Chapel Hill School of Medicine and Lineberger Comprehensive Cancer Center, is serving as the Lead Principal Investigator of VERSATILE-002. Patients interested in enrolling in this clinical study should email info@pdsbiotech.com or visit the website at http://pdsbiotech.com/VERSATILE-002 to learn more.

About PDS Biotechnology

PDS Biotech is a clinical-stage immunotherapy company developing a growing pipeline of cancer immunotherapies based on the Company’s proprietary Versamune® T-cell activating technology platform. Our Versamune®-based products have demonstrated the potential to overcome the limitations of current immunotherapy by inducing in vivo, large quantities of high-quality, highly potent polyfunctional tumor specific CD4+ helper and CD8+ killer T-cells. PDS Biotech has developed multiple therapies, based on combinations of Versamune® and disease-specific antigens, designed to train the immune system to better recognize diseased cells and effectively attack and destroy them. The company’s pipeline products address various cancers including breast, colon, lung, prostate and ovarian cancers. To learn more, please visit www.pdsbiotech.com or follow us on Twitter at @PDSBiotech.

About PDS0101

PDS Biotech’s lead candidate, PDS0101, combines the utility of the Versamune® platform with targeted antigens in HPV-expressing cancers. In partnership with Merck & Co., PDS Biotech is evaluating a combination of PDS0101 and KEYTRUDA® in a Phase 2 study in first-line treatment of recurrent or metastatic head and neck cancer. PDS Biotech is also conducting two additional Phase 2 studies in advanced HPV-associated cancers and locally advanced cervical cancer with the National Cancer Institute (NCI) and The University of Texas MD Anderson Cancer Center, respectively.

Forward Looking Statements

This communication contains forward-looking statements (including within the meaning of Section 21E of the United States Securities Exchange Act of 1934, as amended, and Section 27A of the United States Securities Act of 1933, as amended) concerning PDS Biotechnology Corporation (the “Company”) and other matters. These statements may discuss goals, intentions and expectations as to future plans, trends, events, results of operations or financial condition, or otherwise, based on current beliefs of the Company’s management, as well as assumptions made by, and information currently available to, management. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as “may,” “will,” “should,” “would,” “expect,” “anticipate,” “plan,” “likely,” “believe,” “estimate,” “project,” “intend,” “forecast,” “guidance”, “outlook” and other similar expressions among others. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors, including, without limitation: the Company’s ability to protect its intellectual property rights; the Company’s anticipated capital requirements, including the Company’s anticipated cash runway and the Company’s current expectations regarding its plans for future equity financings; the Company’s dependence on additional financing to fund its operations and complete the development and commercialization of its product candidates, and the risks that raising such additional capital may restrict the Company’s operations or require the Company to relinquish rights to the Company’s technologies or product candidates; the Company’s limited operating history in the Company’s current line of business, which makes it difficult to evaluate the Company’s prospects, the Company’s business plan or the likelihood of the Company’s successful implementation of such business plan; the timing for the Company or its partners to initiate the planned clinical trials for PDS0101, PDS0203 and other Versamune® based products; the future success of such trials; the successful implementation of the Company’s research and development programs and collaborations, including any collaboration studies concerning PDS0101, PDS0203 and other Versamune® based products and the Company’s or monitoring committees’ or other third parties’ interpretation of the results and findings of such programs and collaborations and whether such results are sufficient to support the future success of the Company’s product candidates; the success, timing and cost of the Company’s ongoing clinical trials and anticipated clinical trials for the Company’s current product candidates, including statements regarding the timing of initiation, pace of enrollment, significance of milestones, and completion of the trials (including our ability to fully fund our disclosed clinical trials, which assumes no material changes to our currently projected expenses), futility analyses, presentations at conferences and data reported in an abstract, and receipt of interim results, which are not necessarily indicative of the final results of the Company’s ongoing clinical trials; any Company statements about its understanding of product candidates mechanisms of action and interpretation of preclinical and early clinical results from its clinical development programs and any collaboration studies; the acceptance by the market of the Company’s product candidates, if approved; the timing of and the Company’s ability to obtain and maintain U.S. Food and Drug Administration or other regulatory authority approval of, or other action with respect to, the Company’s product candidates; and other factors, including legislative, regulatory, political and economic developments not within the Company’s control, including unforeseen circumstances or other disruptions to normal business operations arising from or related to COVID-19. The foregoing review of important factors that could cause actual events to differ from expectations should not be construed as exhaustive and should be read in conjunction with statements that are included herein and elsewhere, including the risk factors included in the Company’s annual and periodic reports filed with the SEC. The forward-looking statements are made only as of the date of this press release and, except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

Media & Investor Relations Contact:

Deanne Randolph
PDS Biotech
Phone: +1 (908) 517-3613
Email: drandolph@pdsbiotech.com

Rich Cockrell
CG Capital
Phone: +1 (404) 736-3838
Email: rich@cg.capital

Release – Comstock Acquires Plain Sight Innovations Corporation


Comstock Acquires Plain Sight Innovations Corporation

 

Extensive Portfolio of Pioneering Clean Technologies; Cellulosic Biofuels

VIRGINIA CITY, Nev., Sept. 09, 2021 (GLOBE NEWSWIRE) — Comstock Mining Inc. (NYSE: LODE) (“Comstock” and the “Company”) today announced its acquisition of 100% of the issued and outstanding equity of Plain Sight Innovations Corporation (“PSI”) in exchange for 8,500,000 restricted shares of its common stock, and all of the intellectual property assets of PSI’s affiliate, FLUX Photon Corporation (“FPC”), in exchange for a performance-based cash payment equal to 20% of the Company’s future consolidated net cash flow from operations up to $18,000,000.

PSI’s management team has deep experience in a diverse array of industries, including renewable fuels, hazardous waste, agriproducts, and other commodities with almost thirty years of clean technology research, development, and commercialization expertise, with an emphasis on the extraction and valorization of natural resources.

PSI owns an array of patented, patent-pending and proprietary process technologies that were designed to convert low cost, ubiquitous woody biomass feedstocks into cellulosic ethanol, while producing a portfolio of co-products, including renewable diesel and an extraordinary new form of biomass-derived crystalline graphite, or biographite, with compelling applications in the production of carbon neutral batteries and other electrification components. PSI also operates a commercial pilot cellulosic fuel facility based on its technologies in Wisconsin, where it has already proven the ability to efficiently convert various forms of woody biomass into cellulosic ethanol and co-product precursors for renewable diesel, biographite, bioplastics, and a portfolio of carbon neutral alternatives to fossil fuels.

The Path to Decarbonization is in Plain Sight

The transportation sector is expected to dramatically increase the production of electric vehicles to more than 30% of all auto sales by 2030. However, more than two thirds of the energy required to power those electric vehicles is expected to come from burning fossil fuels, and the direct combustion of liquid fuels will most certainly continue to be the dominant source of power for transportation for decades. Burning less, burning smarter, and reusing emissions are therefore critical objectives as the world moves to clean energy and decarbonization.

“Renewable fuels provide a critical pathway for decarbonization, however, most current forms of renewable fuel draw from the same pool of conventional feedstocks, including corn and various vegetable oils in the U.S., and the entire universe of those feedstocks only represents a tiny fraction of the domestic burn,” said David Winsness, PSI’s founder and Chief Executive Officer. “Unfortunately, the lifecycle carbon benefits of growing, harvesting, and using conventional feedstocks are extremely limited. Our technologies were designed to address that dilemma by converting abundantly available forestry wastes, short rotation energy crops, and other low-cost sources of woody biomass into natural liquid fuels with vastly superior benefits for a fraction of the refining costs of conventional renewable fuels.”

The U.S. Department of Energy has estimated that more than one billion tons of forestry wastes and other forms of biomass will be produced annually by 2027 with continued growth thereafter. That’s enough new feedstock to produce as much as 70 billion gallons per year of advanced carbon neutral fuels with PSI’s proven technologies, or more than one third of the U.S. transportation demand on an energy equivalent basis.

Cellulosic Fuels

“That’s enough feedstock to rapidly neutralize motor fuel emissions in conjunction with America’s transition to electrification and renewable energy,” added Winsness. “PSI’s cellulosic fuels facilities will be the first of their kind, with an expected financial, natural, and social impact far in excess of any other platform, renewable or otherwise.”

PSI’s first facility is expected to scale up to an initial capacity exceeding 330,000 tons per year of forestry wastes over its first three years of operations, as it extracts, converts, and refines biomass into ethanol, renewable diesel fuel, and biographite to generate annualized revenues exceeding $86,000,000, $173,000,000, and $346,000,000 per year during the facility’s first three full years of operations, respectively, as shown in the following summary projections:

      2023     2024     2025     2026
Throughput (tons per year)     33,000     85,500     165,000     330,000
Revenue ($000s per year)   $ 34,626   $ 86,565   $ 173,131   $ 346,262

Comstock’s Executive Chairman and Chief Executive Officer, Corrado De Gasperis, commented, “Cellulosic fuel production, like lithium-ion battery recycling and industrial hemp production, is poised for, and we are planning for, exponential growth. Our guidance for these three businesses represents just one facility each and we are planning for over one hundred cellulosic fuel facilities in the U.S. alone. That level of production barely dents the transportation fuels market, yet it represents a meaningful impact on shifting consumption and the resulting decarbonization.”

Ecosystem of Strategic Feedstocks, Processes, and Products

PSI’s technologies are especially important to the Company’s plans to build a synergistic ecosystem of strategic lines of business and production facilities with complimentary feedstocks and products, supported by world class technological and engineering talent. The Company’s ability to systemically discover, develop, engineer, manufacture and commission its own solutions, represents a remarkable competitive advantage that enables speed.

Benchmark Mineral Intelligence estimates that the major automakers have committed over $300 billion to developing electric vehicles (“EVs”) and that over 2,000 GWh of lithium-ion battery (“LIB”) production capacity is in the pipeline. That amount of production in turn equates to 1.4 million tons of new annual graphite demand by 2028. Conventional graphite comes from natural deposits or the carbonization of petroleum products, with market values ranging from about $10,000 per ton for natural graphite to $20,000 per ton for synthetic graphite.

De Gasperis continued, “Most of my relevant experience comes from managing the global manufacturing of carbon-based, material-science products, particularly synthetic graphite. I was literally stunned by PSI’s discovery of a natural source of carbon neutral biographite. When we consider that every cathode in every lithium-ion battery needs an anode, and most anodes are made from synthetic graphite which is substantially all produced with carbon intensive fossil fuel derivatives, then we understand that that industry is not climate smart or clean. We can fundamentally change the game by introducing the world’s first scalable carbon neutral alternative to fossil fuel derived graphite.”

PSI’s intellectual property portfolio also includes remarkably advanced new approaches to carbon capture and utilization, atmospheric water harvesting, waste heat and energy recovery, and industrial photosynthesis for terascale decarbonization and the sustainable production of very large agricultural outputs for fractional inputs.

About Comstock Mining Inc.
Comstock Mining Inc. (NYSE: LODE) (the “Company”) is an emerging innovator and leader in the sustainable extraction, valorization, and production of scarce natural resources, with a focus on high value strategic materials that are essential to meeting the rapidly increasing global demand for clean energy, carbon-neutrality, and natural products. To learn more, please visit www.comstockmining.com.

Forward-Looking Statements
This press release and any related calls or discussions may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical facts, are forward-looking statements. The words “believe,” “expect,” “anticipate,” “estimate,” “project,” “plan,” “should,” “intend,” “may,” “will,” “would,” “potential” and similar expressions identify forward-looking statements, but are not the exclusive means of doing so.

Forward-looking statements include statements about matters such as: future industry market conditions; future explorations or acquisitions; future changes in our exploration activities; future prices and sales of, and demand for, our products; land entitlements and uses; permits; production capacity and operations; operating and overhead costs; future capital expenditures and their impact on us; operational and management changes (including changes in the Board of Directors); changes in business strategies, planning and tactics; future employment and contributions of personnel, including consultants; future land sales; investments, acquisitions, joint ventures, strategic alliances, business combinations, operational, tax, financial and restructuring initiatives, including the nature, timing and accounting for restructuring charges, derivative assets and liabilities and the impact thereof; contingencies; litigation, administrative or arbitration proceedings; environmental compliance and changes in the regulatory environment; offerings, limitations on sales or offering of equity or debt securities, including asset sales and associated costs; and future working capital, costs, revenues, business opportunities, debt levels, cash flows, margins, taxes, earnings and growth. These statements are based on assumptions and assessments made by our management in light of their experience and their perception of historical and current trends, current conditions, possible future developments and other factors they believe to be appropriate. Forward-looking statements are not guarantees, representations or warranties and are subject to risks and uncertainties, many of which are unforeseeable and beyond our control and could cause actual results, developments and business decisions to differ materially from those contemplated by such forward-looking statements. Some of those risks and uncertainties include the risk factors set forth in our filings with the SEC and the following: adverse effects of climate changes or natural disasters; adverse effects of global or regional pandemic disease spread or other crises; global economic and capital market uncertainties; the speculative nature of gold or mineral exploration, mercury remediation and lithium, nickel and cobalt recycling, including risks of diminishing quantities or grades of qualified resources; operational or technical difficulties in connection with exploration or mercury remediation, metal recycling, processing or mining activities; costs, hazards and uncertainties associated with precious metal based activities, including environmentally friendly and economically enhancing clean mining and processing technologies, precious metal exploration, resource development, economic feasibility assessment and cash generating mineral production; costs, hazards and uncertainties associated with mercury remediation, metal recycling, processing or mining activities; contests over our title to properties; potential dilution to our stockholders from our stock issuances, recapitalization and balance sheet restructuring activities; potential inability to comply with applicable government regulations or law; adoption of or changes in legislation or regulations adversely affecting our businesses; permitting constraints or delays; ability to achieve the benefits of business opportunities that may be presented to, or pursued by, us, including those involving battery technology, mercury remediation technology and efficacy, quantum computing and advanced materials development, and development of cellulosic technology in bio-fuels and related carbon-based material production; ability to successfully identify, finance, complete and integrate acquisitions, joint ventures, strategic alliances, business combinations, asset sales, and investments that we may be party to in the future; changes in the United States or other monetary or fiscal policies or regulations; interruptions in our production capabilities due to capital constraints; equipment failures; fluctuation of prices for gold or certain other commodities (such as silver, zinc, lithium, nickel, cobalt, cyanide, water, diesel, gasoline and alternative fuels and electricity); changes in generally accepted accounting principles; adverse effects of war, mass shooting, terrorism and geopolitical events; potential inability to implement our business strategies; potential inability to grow revenues; potential inability to attract and retain key personnel; interruptions in delivery of critical supplies, equipment and raw materials due to credit or other limitations imposed by vendors; assertion of claims, lawsuits and proceedings against us; potential inability to satisfy debt and lease obligations; potential inability to maintain an effective system of internal controls over financial reporting; potential inability or failure to timely file periodic reports with the Securities and Exchange Commission; potential inability to list our securities on any securities exchange or market or maintain the listing of our securities; and work stoppages or other labor difficulties. Occurrence of such events or circumstances could have a material adverse effect on our business, financial condition, results of operations or cash flows, or the market price of our securities. All subsequent written and oral forward-looking statements by or attributable to us or persons acting on our behalf are expressly qualified in their entirety by these factors. Except as may be required by securities or other law, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Neither this press release nor any related calls or discussions constitutes an offer to sell, the solicitation of an offer to buy or a recommendation with respect to any securities of the Company, the fund or any other issuer.

Contact Information    
Comstock Mining Inc.
P.O. Box 1118
Virginia City, NV 89440
www.comstockmining.com
Corrado De Gasperis
Executive Chairman & CEO
Tel (775) 847-4755
degasperis@comstockmining.com
Zach Spencer
Director of External Relations
Tel (775) 847-5272 Ext.151
questions@comstockmining.com